Miller R Lance, Zhang Ping, Chen Tong, Rohrwasser Andreas, Nelson Raoul D
Department of Pediatrics, School of Medicine, University of Utah, 30 North 1900 East, SOM 2B422, Salt Lake City, UT 84132, USA.
Am J Physiol Renal Physiol. 2006 Jul;291(1):F236-45. doi: 10.1152/ajprenal.00273.2005. Epub 2006 Feb 7.
The structural and functional heterogeneity of the collecting duct present a tremendous experimental challenge requiring manual microdissection, which is time-consuming, labor intensive, and not amenable to high throughput. To overcome these limitations, we developed a novel approach combining the use of transgenic mice expressing green fluorescent protein (GFP) in the collecting duct with large-particle-based flow cytometry to isolate pure populations of tubular fragments from the whole collecting duct (CD), or inner medullary (IMCD), outer medullary (OMCD), or connecting segment/cortical collecting duct (CNT/CCD). Kidneys were enzymatically dispersed into tubular fragments and sorted based on tubular length and GFP intensity using large-particle-based flow cytometry or a complex object parametric analyzer and sorter (COPAS). A LIVE/DEAD assay demonstrates that the tubules were >90% viable. Tubules were collected as a function of fluorescent intensity and analyzed by epifluorescence and phase microscopy for count accuracy, GFP positivity, average tubule length, and time required to collect 100 tubules. Similarly, mRNA and protein from sorted tubules were analyzed for expression of tubule segment-specific genes using quantitative real-time RT-PCR and immunoblotting. The purity and yield of sorted tubules were related to sort stringency. Four to six replicates of 100 collecting ducts (9.68+/-0.44-14.5+/-0.66 cm or 9.2+/-0.7 mg tubular protein) were routinely obtained from a single mouse in under 1 h. In conclusion, large-particle-based flow cytometry is fast, reproducible, and generates sufficient amounts of highly pure and viable collecting ducts from single or replicate animals for gene expression and proteomic analysis.
集合管的结构和功能异质性给实验带来了巨大挑战,需要进行手动显微切割,这既耗时又费力,且不适用于高通量实验。为了克服这些限制,我们开发了一种新方法,将在集合管中表达绿色荧光蛋白(GFP)的转基因小鼠与基于大颗粒的流式细胞术相结合,从整个集合管(CD)、内髓集合管(IMCD)、外髓集合管(OMCD)或连接段/皮质集合管(CNT/CCD)中分离出纯净的肾小管片段群体。将肾脏酶解成肾小管片段,并使用基于大颗粒的流式细胞术或复杂物体参数分析仪及分选仪(COPAS),根据肾小管长度和GFP强度进行分选。一项活/死检测表明,这些肾小管的存活率>90%。根据荧光强度收集肾小管,并通过落射荧光显微镜和相差显微镜分析计数准确性、GFP阳性率、平均肾小管长度以及收集100个肾小管所需的时间。同样,使用定量实时RT-PCR和免疫印迹法分析分选后的肾小管中的mRNA和蛋白质,以检测肾小管节段特异性基因的表达。分选后的肾小管的纯度和产量与分选严格度有关。通常在1小时内从一只小鼠中常规获得4至6组,每组100个集合管(9.68±0.44 - 14.5±0.66厘米或9.2±0.7毫克肾小管蛋白)。总之,基于大颗粒的流式细胞术速度快、可重复,并且能从单个或重复的动物中产生足够数量的高度纯净且有活力的集合管,用于基因表达和蛋白质组分析。